Press Releases

Summary Toggle Arbutus Announces Issuance of Broad New US Patent for LNP Delivery Technology

Aug 08, 2016

Arbutus Announces Issuance of Broad New US Patent for LNP Delivery Technology 17.1 KB

Patent Covers Lipid Particle Compositions Known to be Effective for Delivery of Nucleic Acids Including mRNA VANCOUVER, B.C. and DOYLESTOWN, Pa., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading hepatitis B virus (HBV) therapeutic solutions company,...

Read more
Summary Toggle Arbutus Provides Corporate Update and Announces Second Quarter 2016 Financial Results

Aug 04, 2016

Arbutus Provides Corporate Update and Announces Second Quarter 2016 Financial Results 41 KB

ARB-1467 Clinical Data in HBV Patients on Track for 2H16 Cash Runway Extends into Late 2018 VANCOUVER, British Columbia and DOYLESTOWN, Pa., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company,...

Read more
Summary Toggle Arbutus Reports Topline Results from TKM-PLK1 HCC Clinical Trial

Jul 19, 2016

Arbutus Reports Topline Results from TKM-PLK1 HCC Clinical Trial 20.9 KB

Promising Anti-Tumor Activity Observed Arbutus to Explore Partnership Options to Enable Further Study VANCOUVER, B.C. and DOYLESTOWN, Pa., July 19, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading hepatitis B virus (HBV) therapeutic solutions company, today...

Read more
Summary Toggle Arbutus to Present Data on New LNP Formulations for Delivery of mRNA at the 2016 Controlled Release Society Conference

Jul 18, 2016

Arbutus to Present Data on New LNP Formulations for Delivery of mRNA at the 2016 Controlled Release Society Conference 16.3 KB

In Vivo Data Support Improved Potency of New Lipid Compositions Arbutus' LNP Platform is the Leading Delivery Solution for mRNA Therapeutics VANCOUVER, British Columbia and DOYLESTOWN, Pa., July 18, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis...

Read more
Summary Toggle Arbutus to Present mRNA Delivery Data at the 32nd Annual Meeting of the Japan Society of Drug Delivery System

Jun 30, 2016

In Vivo Data Support Use of Our Proprietary LNP Platform Technology Arbutus Has a Dominant IP Position in LNP-Enabled Delivery VANCOUVER, British Columbia and DOYLESTOWN, Pa., June 30, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV)...

Read more
Summary Toggle Arbutus to Participate in Upcoming Investor Conferences

Jun 03, 2016

Arbutus to Participate in Upcoming Investor Conferences 14.5 KB

VANCOUVER, British Columbia and DOYLESTOWN, Pa., June 03, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that the company will be participating in the following investor conferences....

Read more
Summary Toggle Arbutus to Present at the 5th Antiviral Drugs Research and Development Conference

Jun 01, 2016

Arbutus to Present at the 5th Antiviral Drugs Research and Development Conference 15.5 KB

First In Vivo Data from Arbutus HBV Preclinical Combination Studies Additive Anti-HBV Effects When Combining Capsid Inhibitor AB-423 with Current Standard of Care VANCOUVER, British Columbia and DOYLESTOWN, Pa., June 01, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an...

Read more
Summary Toggle Arbutus Provides Corporate Update and Announces First Quarter 2016 Financial Results

May 04, 2016

Arbutus Provides Corporate Update and Announces First Quarter 2016 Financial Results 39.8 KB

Conference Call at 4:30 pm Eastern Time Today
...

Read more
Summary Toggle Arbutus Expands HBV Pipeline

May 03, 2016

Arbutus Expands HBV Pipeline 15.5 KB

Technology License Enables the Development of RNaseH Inhibitors for HBV
...

Read more
Summary Toggle Arbutus to Provide a Corporate Update and Release First Quarter 2016 Financial Results

Apr 29, 2016

Arbutus to Provide a Corporate Update and Release First Quarter 2016 Financial Results 13.9 KB

Conference Call and Webcast to Follow
...

Read more